T. Yu. Vedenikin

T. Yu. Vedenikin

Auto-generated profile, based on publicly available information

T. Yu. Vedenikin

Veresaev City Clinical Hospital

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ODO. N. Dzhioeva
O. N. Dzhioeva
YTYury Timofeev
Yury Timofeev
VMVictoria A Metelskaya
Victoria A Metelskaya
ABAleksandra Bogdanova
Aleksandra Bogdanova
TVT. Yu. Vedenikin
T. Yu. Vedenikin
ODOxana M. Drapkina
Oxana M. Drapkina
According to the recent World Health Organization statistics, cardiovascular disease (CVD) is one of the leading causes of high mortality worldwide. While obesity is a major and persistent risk factor for CVD, the cause of this condition, the pathological molecular connection between peripheral fat depots and the heart, remains poorly understood. The aim of this review is to introduce the reader to the metabolic activity of epicardial adipose tissue (EAT), the consequences of excessive epicardial fat accumulation and the development of heart failure (HF).EAT is visceral adipose tissue that is in direct contact with the myocardium and coronary vessels and can influence cardiac function through both mechanical effects and more subtle paracrine molecular mechanisms. HF with preserved ejection fraction (HFpEF) is closely associated with obesity and patterns in fat distribution. Excessive amounts of EAT are associated with abnormal hemodynamics in HFpEF, with the potential for direct mechanical effects on the heart causing a constriction-like effect and local myocardial remodeling effects resulting from the secretion of inflammatory mediators. However, patients with excess EAT tend to have more subcutaneous adipose tissue, making it difficult to determine a cause-and-effect relationship between epicardial fat and HFpEF. This review provides evidence that excess EAT is an important part of HFpEF pathogenesis.

20 May 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
YTYury Timofeev
Yury Timofeev
TVT. Yu. Vedenikin
T. Yu. Vedenikin
AAA. R. Afaunova
A. R. Afaunova
RZR. A. Zamyatin
R. A. Zamyatin
VMVictoria A Metelskaya
Victoria A Metelskaya
ВМВ. Н. Метельская
В. Н. Метельская
Aim. To analyze the relationship between the concentrations of circulating heat shock proteins (HSP): HSP27, HSP70 and cardiovascular HSP (cvHSP) with the course of heart failure with preserved ejection fraction (HFpEF) and the outcomes of acute decompensated HFpEF (ADHFpEF).Material and methods. A total of 120 patients with a confirmed diagnosis of HFpEF aged 50 to 90 years and acute decompensated HFpEF at the time of blood sampling, as well as 20 patients with HFpEF without clinical manifestations of ADHFpEF were examined. Before treatment, blood was collected from patients and serum was obtained with subsequent storage at -80 0C for biomarker testing by the enzyme immunoassay (AssayPro, USA and Cloud-Clone, USCN) on a Thermo Multiscan FC microplate photometer (USA). Fatal outcomes were monitored in patients in the interval from 6 months to 1,5 years.Results. The median serum levels of HSP27, HSP70 and cvHSP are significantly higher in patients with decompensated than with compensated HFpEF. Elevated baseline levels of HSP70 (>3,5 ng/ml) and cvHSP (>1321 pg/ml) in patients with ADHFpEF are associated with an unfavorable survival prognosis. For HSP27, no significant differences were found in the survival analysis.Conclusion. An association was found between serum concentrations of HSP70 and cvHSP with an unfavorable survival prognosis in patients with ADHFpEF, which allows them to be considered as potential prognostic markers of this disease.

27 August 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ERE. A. Rogozhkina
E. A. Rogozhkina
TVT. Yu. Vedenikin
T. Yu. Vedenikin
YTYury Timofeev
Yury Timofeev
AIA. A. Ivanova
A. A. Ivanova
AAA. R. Afaunova
A. R. Afaunova
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To characterize the potental of additional paraclinical research methods (ultrasound, determination of body composition) for assessing the congestion severity in patients with acute decompensated heart failure with preserved ejection fraction (ADHFpEF) in the intensive care unit.Material and methods. We examined 82 patients with ADHFpEF aged from 50 to 85 years, who were hospitalized in the intensive care unit of the Veresaev City Clinical Hospital (Moscow). All patients underwent a standard clinical and laboratory examination, including determination of NT-proBNP, as well as echocardiography, chest radiography, bioimpedance analysis, Venous Excess Ultrasound (VExUS), lung ultrasound. Depending on the congestion degree visualized by VExUS, patients were divided into three groups.Results. The median levels of NT-proBNP, E/A and E/e', number of B-lines in one lung segment, ECW and TBW, and the diuretics' dose used in the hospital in pa tients with ADHFpEF and severe congestion were significantly higher. Signs of congestion obtained as a result of X-ray examination did not differ significantly between groups. In-hospital death was associated with higher values of NT-proBNP, E/A ratio, IVC diameter, number of B-lines in one lung segment, ECW and TBW. The odds of death in patients with VExUS Grade 3 increased 20,9 times compared to Grade 1 (95% CI: 1,125-387,688).Conclusion. Higher levels of NT-proBNP, the dose of diuretics used in the hospital, and ECW and TBW were associated with congestion severity. The severity of congestion assessed by VExUS and ECW/TBW are positively associated with inhospital mortality

23 January 2026 in Primary Health Care (Russian Federation)
Verified
Journal Article
Open access
PDF file
ODO. N. Dzhioeva
O. N. Dzhioeva
ERE. A. Rogozhkina
E. A. Rogozhkina
AIA. A. Ivanova
A. A. Ivanova
TVT. Yu. Vedenikin
T. Yu. Vedenikin
ODOxana M. Drapkina
Oxana M. Drapkina
This guideline describes modern approaches to diagnosing acute decompensated heart failure using ultrasound imaging. Key attention is given to ultrasound use in outpatient settings to assess the congestion severity and monitoring of patients with heart failure by primary care physicians. A detailed description of the methodology, algorithms for performing ultrasound-assisted diagnosis of acute decompensated heart failure, and extensive evidence-based rationale make it relevant, practice-oriented, and useful for healthcare professionals. This teaching aid can be used by primary care physicians, cardiologists, general practitioners, and other specialists involved in the clinical management of patients with acute decompensated heart failure.

29 May 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
YTYury Timofeev
Yury Timofeev
AAA. R. Afaunova
A. R. Afaunova
AIA. A. Ivanova
A. A. Ivanova
TVT. Yu. Vedenikin
T. Yu. Vedenikin
ODO. N. Dzhioeva
O. N. Dzhioeva
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To analyze the interactions between heat shock proteins (HSPs) (HSP27, HSP70 and cardiovascular HSP — cvHSP) serum levels and acute decompensated heart failure (HF) and signs of venous congestion in patients with preserved ejection fraction (HFpEF).Material and methods. The study included 80 patients with HFpEF aged from 50 to 85 years: 60 with acute decompensated HF and 20 with stable HFpEF. HSP levels were estimated with the enzyme immunoassay method using AssayPro (USA) and Cloud-­Clone (PRC/USA) reagent kits with detection on a Multiskan FC photometer.Results. The medians of HSP27, HSP 70 and cvHSP in the acute decompensated HFpEF group were significantly higher than in the stable HFpEF group. In the decompensated HFpEF group with mild congestion, the medians of HSP27 (0,58 ng/ml) and cvHSP (905 pg/ml) were significantly lower than in the group of patients with moderate or severe congestion (1,67 ng/ml and 1028 pg/ml, respectively). The medians of HSP27 and cvHSP in the group with ≥3 B-lines in one lung segment were significantly higher than the medians in the group with <3 B-lines by 3,6 times and 1,2 times, respectively.Conclusion. Higher serum levels of HSP27, HSP70 and cvHSP are associated with the acute decompensated HFpEF. HSP27 and cvHSP levels are positively associated with the severity of congestion assessed by VExUS and B-lines.

19 March 2025 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
EME. N. Markova
E. N. Markova
TVT. Yu. Vedenikin
T. Yu. Vedenikin
AKA. A. Kuzub
A. A. Kuzub
NKN. V. Kuchieva
N. V. Kuchieva
ANA. R. Navasardyan
A. R. Navasardyan
ODO. N. Dzhioeva
O. N. Dzhioeva
The article is dedicated to the perioperative management of patients with non-valvular atrial fibrillation (AF) receiving direct oral anticoagulants (DOACs) and undergoing elective surgical interventions or invasive procedures. It discusses key factors influencing the strategy for discontinuing and resuming anticoagulant therapy, including the classification of surgical procedures by bleeding risk, type of anesthesia, creatinine clearance, and the pharmacokinetic properties of specific DOACs. A standardized algorithm is presented to determine the optimal timing for discontinuation and resumption of anticoagulants. The detailed analysis of possible clinical scenarios, such as endoscopic cholecystectomy, tooth extraction, radical prostatectomy, and knee arthroplasty is described. Practical recommendations for perioperative management are offered for each case, considering individual patient characteristics, the risk of thromboembolic and hemorrhagic complications, and the need for venous thromboembolism (VTE) prophylaxis. Special attention is given to challenges in real-world clinical practice, such as a lack of coordination between specialists, differences in the interpretation of guidelines, and the absence of standardized in-hospital protocols. The importance of a multidisciplinary approach is emphasized to ensure balanced decision-making. It highlighted the necessity of an individualized approach when deciding on the discontinuation and resumption of anticoagulant therapy, as well as the importance of standardized protocols to enhance patient safety in AF management. It is recommended to consider the pharmacokinetic properties of the drugs, patient- specific factors, and the planned procedure, along with potential risks. The use of clear algorithms and active multidisciplinary collaboration among clinicians can help minimize both thromboembolic and hemorrhagic complications in the perioperative period.